Antenatal screening for fetal trisomies using microarray-based cell-free DNA testing: A systematic review and meta-analysis.
Julia GeppertChris StintonSamantha JohnsonAileen ClarkeDimitris GrammatopoulosSian Taylor-PhillipsPublished in: Prenatal diagnosis (2019)
Included studies suggest that NIPT using microarray-based cfDNA testing has high sensitivity and specificity for detecting fetal trisomy 21, 18, and 13. However, the evidence base is small and at high risk of bias.